Cathie Wood Senti Biosciences, Inc. Transaction History

Ark Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$0.24 - $0.4 $10,836 - $18,060	-45,150 Reduced 2.77%	1,585,772 $444,000
Q1 2024 Apr 18, 2024	SELL	$0.36 - $0.66 $122,017 - $223,699	-338,938 Reduced 17.21%	1,630,922 $619,000
Q4 2023 Jan 17, 2024	BUY	$0.28 - $0.68 $40,259 - $97,773	143,785 Added 7.87%	1,969,860 $1.3 Million
Q3 2023 Oct 18, 2023	SELL	$0.41 - $0.99 $1,533 - $3,702	-3,740 Reduced 0.2%	1,826,075 $748,000
Q2 2023 Jul 10, 2023	SELL	$0.6 - $1.14 $42,991 - $81,683	-71,652 Reduced 3.77%	1,829,815 $1.15 Million
Q1 2023 Apr 17, 2023	SELL	$1.15 - $2.06 $28,013 - $50,181	-24,360 Reduced 1.26%	1,901,467 $2.24 Million
Q4 2022 Jan 24, 2023	SELL	$1.25 - $65.2 $202,336 - $10.6 Million	-161,869 Reduced 7.75%	1,925,827 $0
Q3 2022 Oct 17, 2022	BUY	$1.33 - $21.7 $2.78 Million - $45.3 Million	2,087,696 New	2,087,696 $4.53 Million

342K

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $172M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.